(CercleFinance.com) – The veterinary biotechnology company TheraVet announced on Wednesday the success of its educational webinar dedicated to canine osteosarcoma, organized in collaboration with the British Veterinary Instrumentation.
The specialist in osteoarticular treatments indicates that 520 veterinarians from the United Kingdom and internationally registered for the event which took place at the end of 2023, including 38% live participants.
The webinar was intended to present the method of treating canine osteosarcoma via ‘Biocera-Vet’ cementoplasty designed by the Walloon company.
TheraVe emphasizes that the content of the meeting was appreciated, with an average rating of 8.4 out of 10, and a whole series of positive feedback from the participating professionals.